Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Syndax Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. It is focused on developing a pipeline of cancer therapies. Its product candidates include Revuforj and Niktimvo. It is developing Revuforj, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged also known as mixed lineage leukemia rearranged, acute leukemias including acute lymphoblastic leukemia and acute myeloid leukemia (AML), and necleophosmin 1, also known as NPM1, mutant AML. It is also exploring the use of Revuforj as a treatment in solid tumors, specifically its activity in metastatic colorectal cancer. It is also developing Niktimvo, a monoclonal antibody that blocks the colony stimulating factor 1 receptor (CSF-1R) in chronic graft-versus-host disease (cGVHD), as well as idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells.
Find out what a historical investment in Syndax Pharmaceuticals would be worth today using our SNDX stock calculator.
Buying SNDX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Syndax Pharmaceuticals in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in SNDX
What is the ticker symbol of Syndax Pharmaceuticals?
The ticker symbol for Syndax Pharmaceuticals is SNDX.
How much is one share of SNDX?
One share of SNDX is valued at $8.72 as of 22 November 2026.
What is the market capitalisation of Syndax Pharmaceuticals SNDX?
As of 22 November 2026 Syndax Pharmaceuticals has a market cap of $785.05M.
What is the 52-week high for Syndax Pharmaceuticals stock?
The Syndax Pharmaceuticals 52-week high stock price is $25.59.
What is the 52-week low for Syndax Pharmaceuticals stock?
The Syndax Pharmaceuticals 52-week low stock price is $8.41.
Can I buy SNDX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SNDX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SNDX on Stake
Buy SNDX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of SNDX from only US$10 with fractional shares